Zhitong Finance App News, Aimeike (300896.SZ) announced that the company's holding subsidiary REGEN Biotech, Inc. (hereinafter referred to as “Korea REGEN Company”) delivered a “Cancellation Letter” to Datou Medical Devices (Shanghai) Co., Ltd. (hereinafter referred to as “Datou Company”) on July 18, 2025, to cancel the exclusive distribution agreement, and withdraw all relevant authorizations of Datou as the exclusive distributor of AestheFill products in mainland China.

Zhitongcaijing · 07/21/2025 14:33
Zhitong Finance App News, Aimeike (300896.SZ) announced that the company's holding subsidiary REGEN Biotech, Inc. (hereinafter referred to as “Korea REGEN Company”) delivered a “Cancellation Letter” to Datou Medical Devices (Shanghai) Co., Ltd. (hereinafter referred to as “Datou Company”) on July 18, 2025, to cancel the exclusive distribution agreement, and withdraw all relevant authorizations of Datou as the exclusive distributor of AestheFill products in mainland China.